Home/Filings/4/0000929638-23-001625
4//SEC Filing

Chung Kevin 4

Accession 0000929638-23-001625

CIK 0001831868other

Filed

May 31, 8:00 PM ET

Accepted

Jun 1, 4:01 PM ET

Size

10.3 KB

Accession

0000929638-23-001625

Insider Transaction Report

Form 4
Period: 2023-05-30
Chung Kevin
Chief Medical Officer
Transactions
  • Purchase

    Common Stock, par value $0.0001 per share

    2023-05-30$0.47/sh+2,300$1,09366,975 total
  • Purchase

    Common Stock, par value $0.0001 per share

    2023-05-30$0.47/sh+5,093$2,39460,675 total
  • Purchase

    Common Stock, par value $0.0001 per share

    2023-05-30$0.48/sh+4,000$1,92064,675 total
  • Purchase

    Common Stock, par value $0.0001 per share

    2023-05-30$0.48/sh+1,150$54668,125 total
Holdings
  • Stock Option (Right to Buy)

    Exercise: $1.84Exp: 2033-04-06Common Stock (66,483 underlying)
    66,483
Footnotes (2)
  • [F1]Includes 44,322 shares of the Issuer's common stock subject to restricted stock units (RSUs), all of which will vest, subject to continued service, on April 6, 2024.
  • [F2]All options reported herein will vest, subject to continued service, on the first anniversary of the date of grant.

Documents

1 file

Issuer

SeaStar Medical Holding Corp

CIK 0001831868

Entity typeother

Related Parties

1
  • filerCIK 0001949950

Filing Metadata

Form type
4
Filed
May 31, 8:00 PM ET
Accepted
Jun 1, 4:01 PM ET
Size
10.3 KB